WellDyne's David Skomo Highlights the Need to Reframe How Obesity Is Viewed

Video

Payers need to reframe how they view obesity as not just a health and wellness issue, but as a progressive chronic disease that needs medication, explained David Skomo, RPh, chief operations officer at WellDyne.

Over 70% of U.S. adults are struggling with their weight, and obesity is linked to 60 comorbidities, noted David Skomo, RPh, chief pharmacy operations officer, WellDyne. Given the growing obesity problem, payers need to reframe how they view the disease as not just a health and wellness issue, but as a progressive chronic disease that needs medication.

Skomo presented on coverage of obesity treatments on the last day of the 2022 PBMI Annual National Conference in Orlando, Florida.

Recent Videos
Gregory Warren, FSA, FCA, MAAA,  Axene Health Partners
Related Content
© 2024 MJH Life Sciences

All rights reserved.